This week, BioPharmaDispatch is using a series to highlight red flags in the Health Technology Assessment Review report, each contributing to undermining access to medicines and other therapeutic interventions.
The HTA Review report - 'Red Flag' number one of five
September 16, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
September agenda puts cancer drugs, RSV prevention and ADHD access in focus
August 31, 2026 - - Latest News -
A decade is more than enough - the case for term limits on advisory committees
August 31, 2026 - - Latest News -
Expansion opens PBS access for more with advanced cancer, but it took a long time
August 31, 2026 - - Latest News -
Sanofi leader urges Australia to look beyond the laboratory in building vaccine capability
August 31, 2026 - - Latest News -
Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter
August 31, 2026 - -
Funding brings a new targeted treatment for Australians with lupus kidney disease
August 31, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - Series 5. Ep.30
August 28, 2026 - - Podcast
